Add as a preferred source on GoogleKelyniam Global Revenue Rises 35% as Company Returns to Operating Profit
Revenue reached $2,954,087, while gross profit increased 41% to $2,383,632 in the nine months ended Sept. 30.
Kelyniam Global, Inc. (OTCID:KLYG) reported a 35% revenue increase for the first nine months of 2026 and returned to operating profit, marking a sharp turnaround from the year-earlier period.
The company generated $2,954,087 in revenue in the nine months through Sept. 30, compared with $2,186,491 during the corresponding period of 2025. It recorded $244,509 in operating income, after an operating loss of $162,373 a year earlier.
Kelyniam posted $2,383,632 in gross profit, a 41% increase from $1,695,496. The company makes custom cranial and craniofacial implants.
Chief Operating Officer Kris Renton credited the performance to the launch of Fusion and higher CustomizedBone unit sales. “Our strong financial results reflect the successful launch of Fusion and higher unit sales of CustomizedBone,” Renton said.
Kelyniam’s Q3 2026 financial statements are available on its website.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.